Royal DSM receives unanimous Federal jury verdict over Lallemand patent infringement

In Illinois, Royal DSM received unanimous jury verdict in a Federal Court in Wisconsin concluding that all glycerol reducing ethanol yeast products sold by Lallemand infringe DSM’s US Patent 8,795,998.

After several failed attempts between the parties to settle out of court, DSM filed suit against Lallemand for infringement of its patent in US Federal Court in Wisconsin. DSM alleged that Lallemand’s glycerol reducing yeast products including Transferm Yield+ and YP3 used in the production of ethanol, infringes DSM’s US 8,795,998 patent. After 7 days of trial the jury concluded that the DSM patent is valid and is being infringed by Lallemand’s glycerol reducing yeast products.